help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Winkler, K.
Right arrow Articles by März, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Winkler, K.
Right arrow Articles by März, W.
The Journal of Clinical Endocrinology & Metabolism Vol. 88, No. 3 1162-1166
Copyright © 2003 by The Endocrine Society

Triglyceride-Rich Lipoproteins Are Associated with Hypertension in Preeclampsia

Karl Winkler, Birgit Wetzka, Michael M. Hoffmann, Isolde Friedrich, Martina Kinner, Manfred W. Baumstark, Hans-Peter Zahradnik, Heinrich Wieland and Winfried März

Departments of Clinical Chemistry (K.W., M.M.H., I.F., H.W.), Obstetrics and Gynecology (B.W., M.K., H.-P.Z.), and Sports Medicine (M.W.B.), University of Freiburg, Germany; and Clinical Institute of Medical and Chemical Laboratory Diagnostics (W.M.), University of Graz, Graz, Austria

Address all correspondence and requests for reprints to: Karl Winkler, M.D., Department of Clinical Chemistry, School of Medicine, Albert Ludwigs-University, Hugstetter Strasse 55, D-79106 Freiburg, Germany. E-mail: kwinkler{at}ukl.uni-freiburg.de.

Disorders of the lipoprotein metabolism are a major cause of endothelial dysfunction that may result in hypertension and proteinuria, clinical hallmarks of preeclampsia (PE). Lipoproteins and low-density lipoprotein (LDL) subfractions were investigated in 15 women with severe PE and compared with 23 women with a normal course of pregnancy. Compared with normal pregnancy, in PE apolipoprotein (apo)B in very low-density lipoprotein was increased by 76% (P = 0.008), and the triglyceride content of intermediate dense lipoproteins (IDL) was increased by 51% (P < 0.001); cholesterol and apoB in LDL were decreased by 26% (P = 0.005) and 23% (P = 0.016), respectively. Although not significant, the LDL profile was dominated by the most buoyant LDL-1. ApoB in the most dense LDL (dLDL), namely LDL-5 and LDL-6, was significantly decreased by 49% (P < 0.001) and 55% (P < 0.001), respectively. Diastolic blood pressure was positively correlated with the triglyceride content of IDL (r = 6.31; P < 0.001 and r = 0.352; P = 0.033 by partial correlation controlling for the presence or absence of PE) and negatively correlated with the concentration of apoB in dLDL (r = -0.500; P = 0.002). In addition, IDL triglycerides correlated negatively with infant birth weight percentile (r = -0.373; P = 0.027) and positively with proteinuria (r = 0.430; P = 0.014). Low birth weight was associated with high IDL triglycerides and low rather than high concentrations of dLDL. Triglyceride-rich remnants are known to cause endothelial dysfunction. Because the triglyceride content of IDL was positively correlated with elevated blood pressure and proteinuria, triglyceride-rich remnant lipoproteins might contribute to the pathophysiology of PE.

Abbreviations: apo, Apolipoprotein; CH, cholesterol; CS, cesarean section; dLDL, dense low-density lipoprotein; HDL, high-density lipoprotein; HL, hepatic lipase; IDL, intermediate dense lipoprotein; LDL, low-density lipoprotein; LPL, lipoprotein lipase; PE, preeclampsia; TG, triglyceride; VLDL, very low-density lipoprotein.




This article has been cited by other articles:


Home page
Reproductive SciencesHome page
Joong Shin Park, K.-J. Oh, E. R. Norwitz, J.-S. Han, H.-J. Choi, Hyo Suk Seong, Yoon Dan Kang, C.-W. Park, Byoung Jae Kim, Jong Kwan Jun, et al.
Identification of Proteomic Biomarkers of Preeclampsia in Amniotic Fluid Using SELDI-TOF Mass Spectrometry
Reproductive Sciences, May 1, 2008; 15(5): 457 - 468.
[Abstract] [PDF]


Home page
J. Nutr.Home page
A. T. Merchant, G. Msamanga, E. Villamor, E. Saathoff, M. O'Brien, E. Hertzmark, D. J. Hunter, and W. W. Fawzi
Multivitamin Supplementation of HIV-Positive Women during Pregnancy Reduces Hypertension
J. Nutr., July 1, 2005; 135(7): 1776 - 1781.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Brea, D. Mosquera, E. Martin, A. Arizti, J. L. Cordero, and E. Ros
Nonalcoholic Fatty Liver Disease Is Associated With Carotid Atherosclerosis: A Case-Control Study
Arterioscler. Thromb. Vasc. Biol., May 1, 2005; 25(5): 1045 - 1050.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Winkler, C. Abletshauser, I. Friedrich, M. M. Hoffmann, H. Wieland, and W. Marz
Fluvastatin Slow-Release Lowers Platelet-Activating Factor Acetyl Hydrolase Activity: A Placebo-Controlled Trial in Patients with Type 2 Diabetes
J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1153 - 1159.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
K. Winkler, T. Konrad, S. Fullert, I. Friedrich, R. Destani, M. W. Baumstark, K. Krebs, H. Wieland, and W. Marz
Pioglitazone Reduces Atherogenic Dense LDL Particles in Nondiabetic Patients With Arterial Hypertension: A double-blind, placebo-controlled study
Diabetes Care, September 1, 2003; 26(9): 2588 - 2594.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society